Health system executives are under growing pressure to adopt artificial intelligence quickly, driven by an expanding pipeline of vendor offerings and heightened board-level expectations. New tools and platforms are arriving on the market so frequently that many organizations feel compelled to act fast. That environment has prompted a counterpoint from leadership at one of the nation’s large systems.
Liz Popwell, system vice president of strategy and international at Chicago-based CommonSpirit Health, is pushing back on the impulse to move at breakneck speed. The reporting indicates Popwell is not opposed to AI adoption itself; rather, she questions the automatic reflex to deploy new technologies simply because they are available or because external pressures demand rapid change.
Executives and boards across health care are weighing how quickly to adopt AI tools. The article highlights three pressures shaping those decisions: a full vendor pipeline of AI products, increasing expectations from governing boards, and the steady arrival of new tools on a weekly basis. In that context, a senior strategy executive publicly urging caution is notable because it signals a potential shift from an uncritical race to be first toward a more deliberative, strategic approach.
Popwell’s remarks, as reported, suggest a preference for deliberate evaluation over impulsive implementation. That perspective can influence internal governance, procurement choices, and clinical or operational pilots. It may also affect how resources are allocated between exploratory projects and established priorities. The source article, however, did not provide details on how CommonSpirit plans to operationalize that philosophy.
The core facts presented in the source are straightforward:
The article did not report any specific policies, pilot projects, governance structures, timelines, or examples of technologies that CommonSpirit is evaluating or rejecting. It also did not include direct quotes, metrics, or descriptions of how CommonSpirit’s approach compares with other health systems. Because those details were absent from the source, they cannot be reported here.
Although the source did not elaborate, the reported pressures—vendor activity, board expectations, and a steady stream of new tools—are common factors that health systems consider when deciding how to adopt technology. When a senior strategy leader urges caution, organizations often weigh issues such as clinical validity, patient safety, regulatory compliance, integration complexity, staff training needs, and the potential to scale pilots into enterprise-wide capabilities. The source, however, did not specify which of these considerations guided Popwell’s comments.
The original article flagged an important managerial stance at CommonSpirit Health, but it offered no reporting on subsequent actions or decisions by the system. It did not describe whether CommonSpirit will adopt a formal moratorium, create new governance processes, expand or limit pilots, or issue new guidance to boards and operational leaders. Future reporting would need to supply those specifics.
Leaders across health care are confronting rapid change in the AI market, and not all are recommending immediate, across-the-board adoption. According to the source, Liz Popwell at CommonSpirit is advocating for a more measured response—endorsing thoughtful adoption rather than reflexive embrace of every new tool. The source did not provide further particulars about CommonSpirit’s plans, so readers should view this as a reported leadership position rather than a detailed roadmap.
Note: This rewrite is based solely on the facts reported in the source. Specific actions, timelines, or program details for CommonSpirit Health were not reported in that article and therefore are not included here.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.